You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pfizer
since
auto-detected in 80 stories
20 days ago
Pfizer made one thing clear this week: It's officially back in the obesity race.
24 days ago
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook ○
The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.
Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more ○
These are the stocks posting the largest moves in early trading.
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial ⊕
The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.
S&P 500 futures climb after index starts February trading on a winning note: Live updates ⊕
Investors this week are digesting more than 100 S&P 500 companies posting earnings results. AMD and Pfizer are among those expected to report on Tuesday.
30 days ago
U.S. names HIV, arthritis drugs for next Medicare price talks ○
found
The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis treatment Xeljanz.
35 days ago
What obesity drugmakers see next in the market: More pills, easier access and drug combinations ⊕
found
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
43 days ago
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference ⊕
found
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.
73 days ago
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off ○
Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.
Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more ○
These are the stocks posting the largest moves in early trading.